Pharsight

Zoladex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7220247 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(1 year, 5 months ago)

US7118552 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(1 year, 5 months ago)

Zoladex is owned by Tersera.

Zoladex contains Goserelin Acetate.

Zoladex has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Zoladex are:

  • US7220247
  • US7118552

Zoladex was authorised for market use on 29 December, 1989.

Zoladex is available in implant;implantation dosage forms.

The generics of Zoladex are possible to be released after 13 April, 2022.

Drugs and Companies using GOSERELIN ACETATE ingredient

Market Authorisation Date: 29 December, 1989

Treatment: NA

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

ZOLADEX family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic